Using prostate-specific antigen doubling time in clinical practice

被引:1
作者
Lee, Andrew K.
D'Amico, Anthony V.
机构
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
prostate cancer; prostate specific antigen; PSA doubling time; PSA velocity;
D O I
10.1111/j.1464-410X.2007.06997.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:243 / 244
页数:3
相关论文
共 12 条
[1]   Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point? [J].
Amling, CL ;
Bergstralh, EJ ;
Blute, ML ;
Slezak, JM ;
Zincke, H .
JOURNAL OF UROLOGY, 2001, 165 (04) :1146-1151
[2]  
Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
[3]  
D'Amico Anthony V, 2004, J Urol, V172, pS42, DOI 10.1097/01.ju.0000141845.99899.12
[4]   Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy [J].
D'Amico, AV ;
Moul, JW ;
Carroll, PR ;
Sun, L ;
Lubeck, D ;
Chen, MH .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (18) :1376-1383
[5]   Who dies from prostate cancer after radical prostatectomy? Influence of post-operative prostate specific antigen doubling time, pathological Gleason sum, and time from surgery to biochemical recurrence [J].
Freedland, SJ ;
Humphreys, EB ;
Mangold, LA ;
Eisenberger, MA ;
Walsh, PC ;
Partin, AW .
JOURNAL OF UROLOGY, 2005, 173 (04) :308-308
[6]   Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy [J].
Freedland, SJ ;
Humphreys, EB ;
Mangold, LA ;
Eisenberger, M ;
Dorey, FJ ;
Walsh, PC ;
Partin, AW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (04) :433-439
[7]   Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy [J].
Lee, AK ;
Levy, LB ;
Cheung, R ;
Kuban, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02) :456-462
[8]   Natural history of progression after PSA elevation following radical prostatectomy [J].
Pound, CR ;
Partin, AW ;
Eisenberger, MA ;
Chan, DW ;
Pearson, JD ;
Walsh, PC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17) :1591-1597
[9]   Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference [J].
Roach, Mack, III ;
Hanks, Gerald ;
Thames, Howard, Jr. ;
Schellhammer, Paul ;
Shipley, William U. ;
Sokol, Gerald H. ;
Sandler, Howard .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (04) :965-974
[10]   Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy [J].
Stephenson A.J. ;
Scardino P.T. ;
Bianco Jr. F.J. ;
Eastham J.A. .
Current Treatment Options in Oncology, 2004, 5 (5) :357-365